Nutraceutical Int'l Corp. Company Profile (NASDAQ:NUTR)

About Nutraceutical Int'l Corp. (NASDAQ:NUTR)

Nutraceutical IntNutraceutical International Corporation is an integrated manufacturer, marketer, distributor and retailer of nutritional supplements and other natural products. The Company's products include vitamins and minerals; herbs; specialty formulas; personal care products; liquid nutritional products; homeopathics; functional foods, and other products. It offers its products to and through domestic health and natural food stores. It acts as a distributor to the Healthy Foods Channel and to certain international markets for certain third-party brands. It manufactures and sells nutritional supplements and other natural products under numerous brands, including Solaray, KAL, Dynamic Health, Nature's Life, LifeTime, Natural Balance, NaturalCare, Health from the Sun, Pioneer, Nutra BioGenesis, Life-flo, Organix South, Heritage Store and Monarch Nutraceuticals. It owns various natural food markets, such as The Real Food Company, Thom's Natural Foods, Cornucopia Community Market and Granola's.

Industry, Sector and Symbol:
  • Sector: Non-Cyclical Consumer Goods & Services
  • Industry: Special Foods & Welbeing Products
  • Sub-Industry: Personal Products
  • Symbol: NASDAQ:NUTR
  • CUSIP: 67060Y10
  • Web:
Average Prices:
  • 50 Day Moving Avg: $41.78
  • 200 Day Moving Avg: $36.64
  • 52 Week Range: $24.92 - $42.45
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 25.03
  • P/E Growth: 0.00
  • Net Margins: 2.86%
  • Return on Equity: 4.11%
  • Return on Assets: 3.02%
  • Debt-to-Equity Ratio: 0.28%
  • Current Ratio: 4.40%
  • Quick Ratio: 1.42%
  • Average Volume: 103,459 shs.
  • Beta: 0.49

Frequently Asked Questions for Nutraceutical Int'l Corp. (NASDAQ:NUTR)

What is Nutraceutical Int'l Corp.'s stock symbol?

Nutraceutical Int'l Corp. trades on the NASDAQ under the ticker symbol "NUTR."

How often does Nutraceutical Int'l Corp. pay dividends? What is the dividend yield for Nutraceutical Int'l Corp.?

Nutraceutical Int'l Corp. declared a quarterly dividend on Friday, March 3rd. Shareholders of record on Monday, March 20th will be given a dividend of $0.125 per share on Wednesday, April 5th. This represents a $0.50 dividend on an annualized basis and a yield of 1.20%. The ex-dividend date is Thursday, March 16th. View Nutraceutical Int'l Corp.'s Dividend History.

How were Nutraceutical Int'l Corp.'s earnings last quarter?

Nutraceutical Int'l Corp. (NASDAQ:NUTR) released its quarterly earnings results on Thursday, April, 27th. The company reported $0.48 earnings per share (EPS) for the quarter. The business had revenue of $61.22 million for the quarter. Nutraceutical Int'l Corp. had a net margin of 2.86% and a return on equity of 4.11%. View Nutraceutical Int'l Corp.'s Earnings History.

When will Nutraceutical Int'l Corp. make its next earnings announcement?

Nutraceutical Int'l Corp. is scheduled to release their next quarterly earnings announcement on Wednesday, November, 15th 2017. View Earnings Estimates for Nutraceutical Int'l Corp..

Who are some of Nutraceutical Int'l Corp.'s key competitors?

Who are Nutraceutical Int'l Corp.'s key executives?

Nutraceutical Int'l Corp.'s management team includes the folowing people:

  • Frank W. Gay II, Chairman of the Board, Chief Executive Officer
  • Bruce R. Hough, President
  • Cory J. McQueen, Chief Financial Officer, Vice President
  • Jeffrey A. Hinrichs, Executive Vice President, Chief Operating Officer, Secretary, Director
  • Gary M. Hume, Executive Vice President
  • Matthew A. Vance, Chief Information Officer, Vice President
  • Daren P. Peterson, Vice President - Operations
  • Christopher B. Neuberger, Vice President - Marketing and Sales
  • Stanley E. Soper, Vice President - Legal Affairs, Assistant Secretary
  • Jason D. Jones, Vice President, Corporate Strategy

Who owns Nutraceutical Int'l Corp. stock?

Nutraceutical Int'l Corp.'s stock is owned by many different of institutional and retail investors. Top institutional investors include WEISS ASSET MANAGEMENT LP (8.76%). View Institutional Ownership Trends for Nutraceutical Int'l Corp..

How do I buy Nutraceutical Int'l Corp. stock?

Shares of Nutraceutical Int'l Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nutraceutical Int'l Corp.'s stock price today?

One share of Nutraceutical Int'l Corp. stock can currently be purchased for approximately $41.80.

MarketBeat Community Rating for Nutraceutical Int'l Corp. (NASDAQ NUTR)
Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  49 (Vote Outperform)
Underperform Votes:  48 (Vote Underperform)
Total Votes:  97
MarketBeat's community ratings are surveys of what our community members think about Nutraceutical Int'l Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Nutraceutical Int'l Corp. (NASDAQ:NUTR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for Nutraceutical Int'l Corp. (NASDAQ:NUTR)
Price Target History for Nutraceutical Int`l Corp. (NASDAQ:NUTR)
Analysts' Ratings History for Nutraceutical Int'l Corp. (NASDAQ:NUTR)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/2/2015Imperial CapitalLower Price Target$32.00 -> $26.00N/AView Rating Details
(Data available from 10/19/2015 forward)


Earnings History for Nutraceutical Int'l Corp. (NASDAQ:NUTR)
Earnings by Quarter for Nutraceutical Int`l Corp. (NASDAQ:NUTR)
Earnings History by Quarter for Nutraceutical Int'l Corp. (NASDAQ NUTR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/15/2017N/AView Earnings Details
4/27/2017Q2 2017$0.48$61.22 millionViewN/AView Earnings Details
1/26/2017Q1 2017$0.46$56.62 millionViewN/AView Earnings Details
11/17/2016Q4 2016$0.41$56.70 millionViewN/AView Earnings Details
7/28/2016Q3$0.65$60.84 millionViewN/AView Earnings Details
4/28/2016Q2$0.49$59.49 millionViewN/AView Earnings Details
1/28/2016Q1$0.45$55.96 millionViewN/AView Earnings Details
7/30/2015Q3$0.40$0.47$56.60 million$54.38 millionViewN/AView Earnings Details
11/20/2014Q4 2014$0.40$0.37$52.44 millionViewN/AView Earnings Details
4/24/2014Q214$0.58$0.44$56.60 million$54.90 millionViewN/AView Earnings Details
1/30/2014Q413$0.42$49.74 million$51.55 millionViewN/AView Earnings Details
11/19/2013Q4$0.42ViewN/AView Earnings Details
1/31/2013Q1 2013$0.34$0.36$46.60 million$49.70 millionViewN/AView Earnings Details
11/20/20120.42$0.42$50.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Nutraceutical Int'l Corp. (NASDAQ:NUTR)
Current Year EPS Consensus Estimate: $1.58 EPS
Next Year EPS Consensus Estimate: $1.67 EPS


Current Dividend Information for Nutraceutical Int'l Corp. (NASDAQ:NUTR)
Most Recent Dividend:4/5/2017
Annual Dividend:$0.25
Dividend Yield:0.60%
Payout Ratio:16.13% (Trailing 12 Months of Earnings)
15.82% (Based on This Year's Estimates)
14.97% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Nutraceutical Int`l Corp. (NASDAQ:NUTR)

Dividend History by Quarter for Nutraceutical Int'l Corp. (NASDAQ NUTR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Nutraceutical Int'l Corp. (NASDAQ:NUTR)
Insider Ownership Percentage: 13.10%
Institutional Ownership Percentage: 75.72%
Insider Trades by Quarter for Nutraceutical Int`l Corp. (NASDAQ:NUTR)
Institutional Ownership by Quarter for Nutraceutical Int`l Corp. (NASDAQ:NUTR)
Insider Trades by Quarter for Nutraceutical Int'l Corp. (NASDAQ:NUTR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/19/2016Jason D JonesVPBuy225$22.55$5,073.75View SEC Filing  
5/15/2015Stanley E SoperVPSell3,818$20.00$76,360.00View SEC Filing  
4/29/2015Stanley E SoperVPSell8,485$20.01$169,784.85View SEC Filing  
4/27/2015Stanley E SoperVPSell3,343$20.00$66,860.00View SEC Filing  
4/7/2015Stanley E SoperVPSell1,300$20.00$26,000.00View SEC Filing  
3/30/2015Stanley E SoperVPSell600$20.00$12,000.00View SEC Filing  
5/28/2014J Kimo EsplinDirectorBuy1,400$24.02$33,628.00View SEC Filing  
9/23/2013Frank W Gay IICEOSell10,000$23.29$232,900.00View SEC Filing  
6/28/2013Frank W Gay IICEOSell10,849$20.25$219,692.25View SEC Filing  
6/21/2013Frank W Gay IICEOSell5,872$20.25$118,908.00View SEC Filing  
6/18/2013J Kimo EsplinDirectorSell7,500$20.03$150,225.00View SEC Filing  
6/17/2013Frank W Gay IICEOSell18,853$19.37$365,182.61View SEC Filing  
6/12/2013Frank W Gay IICEOSell16,158$20.14$325,422.12View SEC Filing  
5/15/2013Stanley E SoperVPSell5,000$18.97$94,850.00View SEC Filing  
5/14/2013Gary M HumeEVPSell2,000$18.80$37,600.00View SEC Filing  
5/14/2013Stanley E SoperVPSell9,668$18.63$180,114.84View SEC Filing  
5/7/2013Christopher B NeubergerVPSell5,020$18.56$93,171.20View SEC Filing  
5/1/2013Andrew W SeelosVPSell4,000$18.09$72,360.00View SEC Filing  
5/1/2013Cory J McqueenCFOSell3,500$17.97$62,895.00View SEC Filing  
3/20/2013Christopher B NeubergerVPSell4,040$19.27$77,850.80View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Nutraceutical Int'l Corp. (NASDAQ:NUTR)
Latest Headlines for Nutraceutical Int'l Corp. (NASDAQ:NUTR)
DateHeadline logoNutraceutical shareholders back go-private deal at $41.80 per share - August 23 at 9:24 AM logoHGGC Completes Acquisition of Nutraceutical International Corporation - August 23 at 9:23 AM logoSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against Nutraceutical International Corporation - August 10 at 8:59 PM logoNutraceutical International Corp. :NUTR-US: Earnings Analysis: Q3, 2017 By the Numbers : July 31, 2017 - July 31 at 11:24 PM logoNutraceutical Reports Fiscal 2017 Q3 Results - July 28 at 6:18 AM logoNutraceutical posts 3Q profit - July 28 at 6:18 AM logoHead to Head Survey: Nutraceutical International Corporation (NASDAQ:NUTR) vs. MEDIFAST INC (MED) - July 23 at 8:32 AM logoReviewing MEDIFAST INC (MED) & Nutraceutical International Corporation (NASDAQ:NUTR) - July 22 at 6:29 PM logoHead-To-Head Contrast: MEDIFAST INC (MED) versus Nutraceutical International Corporation (NUTR) - July 15 at 2:20 PM logoNeutriSci Announces Warrant Incentive Program - July 8 at 11:11 PM logo[$$] Does Mario Gabelli See Steve Young Fumbling? - July 8 at 1:09 PM logoFinancial Contrast: Nutraceutical International Corporation (NASDAQ:NUTR) & Medifast (MED) - July 6 at 10:20 PM logoMid-Day Market Update: Nutraceutical Surges After Acquisition News; Diana Containerships Shares Sllide - May 22 at 12:50 PM logoMid-Morning Market Update: Markets Open Higher; Booz Allen Tops Q4 Views - May 22 at 11:22 AM logoNUTRACEUTICAL INTERNATIONAL CORP Files SEC form 8-K, Other Events - March 3 at 6:56 PM logoNutraceutical Reports Fiscal 2017 Q1 Results - January 26 at 11:43 PM logoNUTRACEUTICAL INTERNATIONAL CORP Files SEC form 10-Q, Quarterly Report - January 26 at 11:43 PM logoNUTRACEUTICAL INTERNATIONAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme - January 26 at 11:43 PM logoModere Announces Agreement to Acquire Jusuru International - January 19 at 5:35 AM logoGlobal Flavonoids Market Size & Trend Analysis 2014-2025: Market is Expected to Reach USD 1.06 Billion - Research and Markets - January 17 at 7:19 PM logoGlobal Market Study on Bio-Tech Flavors: Vanilla & Vanillin Flavor Type Segment Projected to Be the Most Prominent Segment over the Forecast Period - January 13 at 5:34 AM logoNUTRACEUTICAL INTERNATIONAL CORP Files SEC form 8-K, Financial Statements and Exhibits - December 16 at 7:40 PM



Nutraceutical Int'l Corp. (NUTR) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.